Abstract:Covalently closed circular DNA (cccDNA) of hepadnaviruses exists as an episomal minichromosome in the nucleus of an infected hepatocyte and serves as the template for the transcription of viral mRNAs. It had been demonstrated by others and us that interferon alpha (IFN-α) treatment of hepatocytes induced a prolonged suppression of human and duck hepatitis B virus cccDNA transcription, which is associated with the reduction of cccDNA-associated histone modifications specifying active transcription (H3K9ac or H3K27ac), but not the histone modifications marking constitutive (H3K9me3) or facultative (H3K27me3) heterochromatin formation. In our efforts to identify IFN-induced cellular proteins that mediate the suppression of cccDNA transcription by the cytokine, we found that downregulating the expression of signal transducer and activator of transcription 1 (STAT1), structural maintenance of chromosomes flexible hinge domain containing 1 (SMCHD1), or promyelocytic leukemia (PML) protein increased basal level of cccDNA transcription activity and partially attenuated IFN-α suppression of cccDNA transcription. In contrast, ectopic expression of STAT1, SMCHD1, or PML significantly reduced cccDNA transcription activity. SMCHD1 is a noncanonical SMC family protein and implicated in epigenetic silencing of gene expression. PML is a component of nuclear domain 10 (ND10) and is involved in suppressing the replication of many DNA viruses. Mechanistic analyses demonstrated that STAT1, SMCHD1, and PML were recruited to cccDNA minichromosomes and phenocopied the IFN-α-induced posttranslational modifications of cccDNA-associated histones. We thus conclude that STAT1, SMCHD1, and PML may partly mediate the suppressive effect of IFN-α on hepadnaviral cccDNA transcription.IMPORTANCE Pegylated IFN-α is the only therapeutic regimen that can induce a functional cure of chronic hepatitis B in a small, but significant, fraction of treated patients. Understanding the mechanisms underlying the antiviral functions of IFN-α in hepadnaviral infection may reveal molecular targets for development of novel antiviral agents to improve the therapeutic efficacy of IFN-α. By a loss-of-function genetic screening of individual IFN-stimulated genes (ISGs) on hepadnaviral mRNAs transcribed from cccDNA, we found that downregulating the expression of STAT1, SMCHD1, or PML significantly increased the level of viral RNAs without altering the level of cccDNA. Mechanistic analyses indicated that those cellular proteins are recruited to cccDNA minichromosomes and induce the posttranslational modifications of cccDNA-associated histones similar to those induced by IFN-α treatment. We have thus identified three IFN-α-induced cellular proteins that suppress cccDNA transcription and may partly mediate IFN-α silencing of hepadnaviral cccDNA transcription.

IFN-λ4 desensitizes the response to IFN-α treatment in chronic hepatitis C through long-term induction of USP18.

Ifn-Lambda 4 Desensitizes The Response To Ifn-Alpha Treatment In Chronic Hepatitis C Through Long-Term Induction Of Usp18

IFN-l 4 desensitizes the response to IFNa treatment in chronic hepatitis C through long-term induction of USP 18

USP18attenuates the Anti-Hepatitis B Virus Effect of IFN by Down Regulating JAK-STAT Pathway

Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells Via JAK/STAT Signaling

Ubiquitin Specific Protease 18 Inhibits the Anti-Hepatitis B Virus Activity of Interferon-Alpha, but Does Not Inhibit Interferon-Lambda in HepG2.2.15 Cells

Intracellular Accumulation of IFN-λ4 Induces ER Stress and Results in Anti-Cirrhotic but Pro-HCV Effects

The role of USP 18 in interferon signaling and inflammation

[Inhibition of IFN-gamma Receptor Signaling by Hepatitis C Virus Non-Structural Protein NS4B].

The Ubiquitin-Specific Protease 18 Promotes Hepatitis C Virus Production by Increasing Viral Infectivity

Transcriptional Response of USP18 Predicts Treatment Outcomes of Interferon-Alpha in HBeAg-positive Chronic Hepatitis B Patientsefere

Alpha Interferon Induces Distinct Translational Control Programs to Suppress Hepatitis C Virus RNA Replication.

Hepatitis C Virus Ns5a Disrupts Stat1 Phosphorylation and Suppresses Type I Interferon Signaling

PD-L1 upregulation by IFN-α/γ-mediated Stat1 suppresses anti-HBV T cell response

Interferon Alpha Induces Multiple Cellular Proteins That Coordinately Suppress Hepadnaviral Covalently Closed Circular DNA Transcription

Transcriptome analysis reveals a classical interferon signature induced by IFNλ4 in human primary cells

Proapoptotic IL-18 in Patients with Chronic Hepatitis C Treated with Pegylated Interferon-Alpha

Expression of Interferon-Alpha/Beta Receptor Protein in Liver of Patients with Hepatitis C Virus-Related Chronic Liver Disease

Interferon Lambda 4 Polymorphism Predicts Sustained Viral Response In Hepatitis C Virus Patients Irrespective Of Hepatitis C Virus Genotypes, Ethnicity Or Treatment Regimen: Results From A Meta-Analysis

Hepatitis C Virus Ns4b Blocks the Interaction of Sting and Tbk1 to Evade Host Innate Immunity

Reduction in p48-ISGFγ Levels Confers Resistance to Interferon-α<sub>2a</sub> in MHCC97 Cells